Free Trial

Warby Parker (WRBY) Stock Forecast & Price Target

Warby Parker logo
$21.45 +0.11 (+0.52%)
(As of 11/15/2024 ET)

Warby Parker - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
8

Based on 12 Wall Street analysts who have issued ratings for Warby Parker in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 4 have given a hold rating, and 8 have given a buy rating for WRBY.

Consensus Price Target

$18.18
-15.24% Downside
According to the 12 analysts' twelve-month price targets for Warby Parker, the average price target is $18.18. The highest price target for WRBY is $23.00, while the lowest price target for WRBY is $14.00. The average price target represents a forecasted downside of -15.24% from the current price of $21.45.
Get the Latest News and Ratings for WRBY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Warby Parker and its competitors.

Sign Up

WRBY Analyst Ratings Over Time

TypeCurrent Forecast
11/17/23 to 11/16/24
1 Month Ago
10/18/23 to 10/17/24
3 Months Ago
8/19/23 to 8/18/24
1 Year Ago
11/17/22 to 11/17/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$18.18$16.71$16.57$16.67
Forecasted Upside-15.24% Downside3.49% Upside14.36% Upside51.52% Upside
Consensus Rating
Moderate Buy
Hold
Hold
Moderate Buy

WRBY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WRBY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Warby Parker Stock vs. The Competition

TypeWarby ParkerMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-15.24% Downside28,534.42% Upside9.87% Upside
News Sentiment Rating
Positive News

See Recent WRBY News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/8/2024Piper Sandler
2 of 5 stars
 Boost TargetOverweight ➝ Overweight$18.00 ➝ $22.00+13.29%
11/8/2024Robert W. Baird
2 of 5 stars
 Boost TargetOutperform ➝ Outperform$18.00 ➝ $23.00+19.11%
11/7/2024William Blair
2 of 5 stars
D. Carden
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
11/7/2024Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$19.00 ➝ $19.00+0.18%
11/1/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$18.00 ➝ $20.00+13.70%
10/21/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Roach
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$15.00 ➝ $18.00+8.76%
10/21/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$15.00 ➝ $18.00+8.76%
8/23/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$20.00+44.30%
8/9/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$14.00 ➝ $15.00+6.99%
7/10/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$15.00 ➝ $16.00+1.65%
5/10/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$13.00 ➝ $15.00+0.07%
5/10/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$13.00 ➝ $14.00-7.59%
10/3/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$20.00+50.77%
8/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$13.00 ➝ $14.00+4.48%
3/1/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$23.00 ➝ $17.00+30.67%
12/15/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$20.00+28.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 08:35 PM ET.


WRBY Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Warby Parker is $18.18, with a high forecast of $23.00 and a low forecast of $14.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Warby Parker in the last twelve months. There are currently 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" WRBY shares.

According to analysts, Warby Parker's stock has a predicted downside of -15.24% based on their 12-month stock forecasts.

Over the previous 90 days, Warby Parker's stock had 4 upgrades by analysts.

Analysts like Warby Parker less than other "medical" companies. The consensus rating score for Warby Parker is 2.67 while the average consensus rating score for "medical" companies is 2.80. Learn more on how WRBY compares to other companies.


This page (NYSE:WRBY) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners